Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin

NCT00973986 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Atorvastatin

Sponsor

Liuhuaqiao Hospital

Collaborators

[object Object]